InsideArbitrage Event Driven Monitor – February 10, 2023

Quick updates on the event driven strategies we follow on InsideArbitrage.

Merger Arbitrage

1. The merger of NuVasive (NUVA) with Globus Medical (GMED) for $3.97 billion in an all stock deal. Under the terms of the agreement, shareholders of NuVasive will receive 0.75 of a share of Globus Medical Class A common stock for each share of NuVasive common stock.
2. Sumo Logic (SUMO) to be acquired by Francisco Partners for $1.1 billion or $12.05 per share in cash.
3. F-star Therapeutics (FSTX) and invoX Pharma extended the tender offer to February 22, 2023, unless further extended. The purpose of the extension is to provide additional time for the Parties to complete their negotiations with CFIUS on the definitive terms of a mitigation agreement.

Only plus or premium subscribers can access this post. Subscribe today.